Hexabrix 320 is a radiopaque contrast agent produced in Germany by Bick Gulden GmbH.
The international name of the drug is ioxagloic acid. Hexabrix 320 is available in the form of an injection solution.
The drug is intended for X-ray examinations - intravenous urography, angiography, computed tomography, etc.
Hexabrix 320 contains iopromide, an iodine-containing non-ionic contrast agent. The effect of the drug is based on increasing the X-ray density of the blood, which allows one to obtain a contrast image of blood vessels, body cavities and internal organs.
Hexabrix 320 is well tolerated and has a low risk of side effects.